Cell Growth & Differentiation, Vol 4, Issue 2 115-123, Copyright © 1993 by American Association of Cancer Research

ARTICLES

Repression of autocrine transforming growth factor beta 1 and beta 2 in quiescent CBS colon carcinoma cells leads to progression of tumorigenic properties

SP Wu, LZ Sun, JK Willson, L Humphrey, R Kerbel and MG Brattain
Department of Biochemistry and Molecular Biology, Medical College of Ohio, Toledo 43699-0008.

Previous work has shown that repression of negative autocrine transforming growth factor (TGF) beta 1 did not alter the growth rate of a human colon carcinoma cell line, but the time required for the cells to enter exponential growth from lag phase was reduced (S. P. Wu, D. Theodorescu, R. Kerbel, J. K. V. Willson, K. M. Mulder, L. E. Humphrey, and M. G. Brattain, J. Cell Biol., 116: 187-196, 1992). These results have led to the hypothesis that the tumor suppressive activity of autocrine TGF-beta 1 was directed at quiescent nondividing cells rather than actively dividing cells. In order to test this hypothesis, a weakly tumorigenic, well-differentiated human colon carcinoma cell line designated CBS, which expressed autocrine TGF-beta 1 and -beta 2 activity in quiescent cells, but not in exponential growth phase cells, was identified. This cell line was stably transfected with a full-length TGF-beta 1 antisense complementary DNA. Constitutive expression of TGF-beta 1 antisense mRNA in CBS cells resulted in repression of autocrine TGF-beta 1 and -beta 2 protein activity in quiescent cells of approximately 10-fold. TGF-beta 2 repression could have been due to interaction with TGF-beta 1 antisense mRNA, since these two isoforms have a high degree of homology, or it could have been indirectly due to TGF-beta 1 repression, since this isoform has been shown to affect transcriptional and posttranscriptional control of TGF-beta 2.(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				J. Wang, L. Yang, J. Yang, K. Kuropatwinski, W. Wang, X.-Q. Liu, J. Hauser, and M. G. Brattain Transforming Growth Factor {beta} Induces Apoptosis through Repressing the Phosphoinositide 3-Kinase/AKT/Survivin Pathway in Colon Cancer Cells Cancer Res., May 1, 2008; 68(9): 3152 - 3160. [Abstract] [Full Text] [PDF]

				S.S. Prime, M. Davies, M. Pring, and I.C. Paterson THE ROLE OF TGF-{beta} IN EPITHELIAL MALIGNANCY AND ITS RELEVANCE TO THE PATHOGENESIS OF ORAL CANCER (PART II) Crit. Rev. Oral. Biol. Med., November 1, 2004; 15(6): 337 - 347. [Abstract] [Full Text] [PDF]

				J. Wang, N. Sergina, T. C. Ko, J. Gong, and M. G. Brattain Autocrine and Exogenous Transforming Growth Factor {beta} Control Cell Cycle Inhibition through Pathways with Different Sensitivity J. Biol. Chem., September 17, 2004; 279(38): 40237 - 40244. [Abstract] [Full Text] [PDF]

				S. Ammanamanchi, M. P. M. Tillekeratne, T. C. Ko, and M. G. Brattain Endogenous Control of Cell Cycle Progression by Autocrine Transforming Growth Factor {beta} in Breast Cancer Cells Cancer Res., April 1, 2004; 64(7): 2509 - 2515. [Abstract] [Full Text] [PDF]

				L. Zawel, J. Yu, C. J. Torrance, S. Markowitz, K. W. Kinzler, B. Vogelstein, and S. Zhou DEC1 is a downstream target of TGF-beta with sequence-specific transcriptional repressor activities PNAS, March 5, 2002; 99(5): 2848 - 2853. [Abstract] [Full Text] [PDF]

				H. Yang, S. Kyo, M. Takatura, and L. Sun Autocrine Transforming Growth Factor {beta} Suppresses Telomerase Activity and Transcription of Human Telomerase Reverse Transcriptase in Human Cancer Cells Cell Growth Differ., February 1, 2001; 12(2): 119 - 127. [Abstract] [Full Text]

				S. Markowitz DNA Repair Defects Inactivate Tumor Suppressor Genes and Induce Hereditary and Sporadic Colon Cancers J. Clin. Oncol., November 1, 2000; 18(90001): 75s - 80. [Full Text] [PDF]

				S.-C. Ye, J. M. Foster, W. Li, J. Liang, E. Zborowska, S. Venkateswarlu, J. Gong, M. G. Brattain, and J. K. V. Willson Contextual Effects of Transforming Growth Factor {beta} on the Tumorigenicity of Human Colon Carcinoma Cells Cancer Res., September 1, 1999; 59(18): 4725 - 4731. [Abstract] [Full Text] [PDF]

				D. Wang, L. Sun, E. Zborowska, J. K. V. Willson, J. Gong, J. Verraraghavan, and M. G. Brattain Control of Type II Transforming Growth Factor-beta Receptor Expression by Integrin Ligation J. Biol. Chem., April 30, 1999; 274(18): 12840 - 12847. [Abstract] [Full Text] [PDF]

				J. Won, H. Kim, E. J. Park, Y. Hong, S.-J. Kim, and Y. Yun Tumorigenicity of Mouse Thymoma Is Suppressed by Soluble Type II Transforming Growth Factor {beta} Receptor Therapy Cancer Res., March 1, 1999; 59(6): 1273 - 1277. [Abstract] [Full Text] [PDF]

				S. Ammanamanchi, S.-J. Kim, L.-Z. Sun, and M. G. Brattain Induction of Transforming Growth Factor-beta Receptor Type II Expression in Estrogen Receptor-positive Breast Cancer Cells through SP1 Activation by 5-Aza-2'-deoxycytidine J. Biol. Chem., June 26, 1998; 273(26): 16527 - 16534. [Abstract] [Full Text] [PDF]

				G. Wu, R. S. Fan, W. Li, V. Srinivas, and M. G. Brattain Regulation of Transforming Growth Factor-beta Type II Receptor Expression in Human Breast Cancer MCF-7 Cells by Vitamin D3 and Its Analogues J. Biol. Chem., March 27, 1998; 273(13): 7749 - 7756. [Abstract] [Full Text] [PDF]

				S. Zhou, P. Buckhaults, L. Zawel, F. Bunz, G. Riggins, J. Le Dai, S. E. Kern, K. W. Kinzler, and B. Vogelstein Targeted deletion of Smad4 shows it is required for transforming growth factor beta  and activin signaling in colorectal cancer cells PNAS, March 3, 1998; 95(5): 2412 - 2416. [Abstract] [Full Text] [PDF]

				L. Sun and C. Chen Expression of Transforming Growth Factor beta  Type III Receptor Suppresses Tumorigenicity of Human Breast Cancer MDA-MB-231 Cells J. Biol. Chem., October 3, 1997; 272(40): 25367 - 25372. [Abstract] [Full Text] [PDF]

				C. Chen, X.-F. Wang, and L. Sun Expression of Transforming Growth Factor beta  (TGFbeta ) Type III Receptor Restores Autocrine TGFbeta 1 Activity in Human Breast Cancer MCF-7 Cells J. Biol. Chem., May 9, 1997; 272(19): 12862 - 12867. [Abstract] [Full Text] [PDF]

				M. T. Hartsough, R. S. Frey, P. A. Zipfel, A. Buard, S. J. Cook, F. McCormick, and K. M. Mulder Altered Transforming Growth Factor beta Signaling in Epithelial Cells when Ras Activation Is Blocked J. Biol. Chem., September 13, 1996; 271(37): 22368 - 22375. [Abstract] [Full Text] [PDF]

				J. Wang, W. Han, E. Zborowska, J. Liang, X. Wang, J. K.V. Willson, L. Sun, and M. G. Brattain Reduced Expression of Transforming Growth Factor beta Type I Receptor Contributes to the Malignancy of Human Colon Carcinoma Cells J. Biol. Chem., July 19, 1996; 271(29): 17366 - 17371. [Abstract] [Full Text] [PDF]

				S Markowitz, J Wang, L Myeroff, R Parsons, L Sun, J Lutterbaugh, R. Fan, E Zborowska, K. Kinzler, B Vogelstein, et al. Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability Science, June 2, 1995; 268(5215): 1336 - 1338. [Abstract] [PDF]